Metropolitan Life Insurance Company (MetLife)’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,561
Closed -$159K 2468
2023
Q2
$159K Buy
1,561
+66
+4% +$6.73K 0.01% 782
2023
Q1
$136K Sell
1,495
-290
-16% -$26.4K 0.01% 842
2022
Q4
$67.8K Hold
1,785
﹤0.01% 1288
2022
Q3
$44.9K Hold
1,785
﹤0.01% 1533
2022
Q2
$54.2K Hold
1,785
﹤0.01% 1450
2022
Q1
$58.5K Sell
1,785
-5,754
-76% -$189K ﹤0.01% 1510
2021
Q4
$199K Hold
7,539
﹤0.01% 2032
2021
Q3
$758K Buy
7,539
+8
+0.1% +$805 0.01% 1161
2021
Q2
$1.07M Buy
7,531
+5,775
+329% +$817K 0.02% 965
2021
Q1
$175K Buy
1,756
+74
+4% +$7.38K ﹤0.01% 2114
2020
Q4
$208K Sell
1,682
-33
-2% -$4.08K ﹤0.01% 1913
2020
Q3
$167K Sell
1,715
-21
-1% -$2.05K ﹤0.01% 1898
2020
Q2
$271K Sell
1,736
-5,144
-75% -$803K ﹤0.01% 1612
2020
Q1
$993K Buy
6,880
+72
+1% +$10.4K 0.02% 684
2019
Q4
$1.39M Buy
6,808
+209
+3% +$42.7K 0.02% 727
2019
Q3
$530K Buy
6,599
+419
+7% +$33.6K 0.01% 1253
2019
Q2
$583K Buy
6,180
+109
+2% +$10.3K 0.01% 1213
2019
Q1
$519K Hold
6,071
0.01% 1271
2018
Q4
$341K Hold
6,071
0.01% 1471
2018
Q3
$496K Buy
6,071
+611
+11% +$50K 0.01% 1354
2018
Q2
$191K Buy
5,460
+1,897
+53% +$66.3K ﹤0.01% 1972
2018
Q1
$73.1K Hold
3,563
﹤0.01% 2407
2017
Q4
$101K Sell
3,563
-2,929
-45% -$83K ﹤0.01% 2306
2017
Q3
$202K Hold
6,492
﹤0.01% 2265
2017
Q2
$205K Buy
+6,492
New +$205K ﹤0.01% 2326